Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CMRX

Chimerix Inc

Nov 30 • 04:00PM ET

0.9726

Dollar change +0.0220
Percentage change 2.31	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	10.69%	Shs Outstand	88.05M	Perf Week	1.24%
Market Cap	86.45M	Forward P/E	-	EPS next Y	-0.82	Insider Trans	0.38%	Shs Float	79.39M	Perf Month	3.26%
Income	-84.89M	PEG	-	EPS next Q	-0.24	Inst Own	45.87%	Short Float / Ratio	1.77% / 3.05	Perf Quarter	-14.68%
Sales	1.13M	P/S	76.51	EPS this Y	-149.26%	Inst Trans	-1.70%	Short Interest	1.41M	Perf Half Y	-30.03%
Book/sh	2.34	P/B	0.42	EPS next Y	13.75%	ROA	-32.70%	Target Price	7.00	Perf Year	-55.79%
Cash/sh	2.19	P/C	0.44	EPS next 5Y	-	ROE	-35.21%	52W Range	0.88 - 2.39	Perf YTD	-47.71%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-40.47%	52W High	-59.39%	Beta	1.10
Dividend %	-	Quick Ratio	12.93	Sales past 5Y	324.59%	Gross Margin	98.98%	52W Low	10.52%	ATR	0.05
Employees	89	Current Ratio	12.93	Sales Q/Q	-99.97%	Oper. Margin	-8471.69%	RSI (14)	50.17	Volatility	3.14% 6.49%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-109.85%	Profit Margin	-7486.24%	Rel Volume	0.70	Prev Close	0.95
Shortable	Yes	LT Debt/Eq	0.01	Earnings	Nov 02 BMO	Payout	0.00%	Avg Volume	461.57K	Price	0.97
Recom	1.29	SMA20	-0.15%	SMA50	-0.52%	SMA200	-17.43%	Volume	323,141	Change	2.31%

Date	Action	Analyst	Rating Change	Price Target Change
May-23-23	Initiated	Robert W. Baird	Outperform	$7
Sep-07-22	Initiated	CapitalOne	Overweight	$7
Apr-29-21	Initiated	Maxim Group	Buy	$20
Apr-23-21	Resumed	Cowen	Outperform	$10 → $18
Mar-31-21	Initiated	Wedbush	Outperform	$21
Mar-31-21	Initiated	Jefferies	Buy	$21
Feb-14-18	Downgrade	JP Morgan	Neutral → Underweight
Feb-02-18	Initiated	H.C. Wainwright	Buy	$10
Aug-09-16	Reiterated	FBR Capital	Mkt Perform	$9 → $8
Feb-23-16	Reiterated	FBR Capital	Mkt Perform	$14 → $10
Feb-23-16	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Feb-23-16	Downgrade	Barclays	Overweight → Equal Weight	$12 → $6
Feb-22-16	Downgrade	Citigroup	Buy → Neutral
Dec-29-15	Downgrade	JP Morgan	Overweight → Neutral	$65 → $15
Dec-28-15	Reiterated	Piper Jaffray	Overweight	$63 → $10
Dec-28-15	Downgrade	FBR Capital	Outperform → Mkt Perform	$73 → $14
Dec-17-15	Initiated	UBS	Buy	$55
Oct-05-15	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Sep-03-15	Initiated	Citigroup	Buy
Aug-18-15	Initiated	FBR Capital	Outperform	$73

Show Previous Ratings

Nov-24-23 07:00AM	Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-16-23 07:00AM	Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer (GlobeNewswire)
Nov-03-23 09:12AM	Chimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call Transcript (Insider Monkey) +8.16%
01:34AM	Q3 2023 Chimerix Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-02-23 10:08AM	Chimerix Inc (CMRX) Reports Q3 2023 Financial Results and Operational Updates (GuruFocus.com)
07:10AM	Loading…
07:10AM	Chimerix: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Chimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Oct-26-23 07:00AM	Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023 (GlobeNewswire)
Oct-23-23 10:08AM	12 Best Penny Stocks to Buy Under $1 (Insider Monkey)
Sep-05-23 07:00AM	Chimerix to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-16-23 10:05AM	Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery" (GlobeNewswire)
Aug-11-23 06:15AM	CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague. (InvestorPlace)
Aug-03-23 08:25AM	Chimerix (CMRX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:19AM	Chimerix: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
07:54AM	Loading…
Jul-31-23 07:54AM	10 Best Growth Stocks for the Next 10 Years (Insider Monkey)
Jul-30-23 02:17PM	7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes (InvestorPlace)
Jul-28-23 04:19PM	10 Best Rated Penny Stocks to Buy According to Analysts (Insider Monkey)
Jul-27-23 10:53AM	With 51% ownership, Chimerix, Inc. (NASDAQ:CMRX) boasts of strong institutional backing (Simply Wall St.)
07:00AM	Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023 (GlobeNewswire)
06:00AM	7 Small-Cap Stocks to Buy Before the Breakout (InvestorPlace)
Jul-11-23 08:53PM	Why These 7 Stocks Are the Best Ways to Play Biotech Right Now (InvestorPlace)
Jun-28-23 02:58PM	Durham drugmaker Chimerix names new CEO at pivotal time (American City Business Journals)
Jun-27-23 04:05PM	Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer (GlobeNewswire)
Jun-01-23 08:04PM	7 Deeply Undervalued Growth Stocks to Buy in June (InvestorPlace)
May-31-23 04:01PM	Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference (GlobeNewswire)
May-25-23 07:00AM	Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House (GlobeNewswire) -5.56%
May-05-23 06:11AM	Chimerix First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
May-04-23 08:25AM	Chimerix (CMRX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:17AM	Chimerix: Q1 Earnings Snapshot (AP Finance)
07:00AM	Loading…
07:00AM	Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update (GlobeNewswire)
Apr-27-23 07:00AM	Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023 (GlobeNewswire)
Apr-18-23 04:01PM	Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting (GlobeNewswire)
Mar-29-23 10:13AM	12 Cheap Healthcare Stocks to Buy in 2023 (Insider Monkey)
09:35AM	Chimerix (CMRX) Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-06-23 05:51AM	Chimerix, Inc. (NASDAQ:CMRX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-03-23 06:57PM	The Top 7 Growth Stocks in Biotech (InvestorPlace)
Mar-02-23 10:10PM	Q4 2022 Chimerix Inc Earnings Call (Thomson Reuters StreetEvents) +6.29%
07:00AM	Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update (GlobeNewswire)
Feb-28-23 04:05PM	Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference (GlobeNewswire)
Feb-23-23 07:00AM	Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023 (GlobeNewswire)
Feb-17-23 09:04AM	With 53% ownership of the shares, Chimerix, Inc. (NASDAQ:CMRX) is heavily dominated by institutional owners (Simply Wall St.)
Feb-13-23 05:55PM	7 Overlooked Value Stocks That Could Outperform the Market (InvestorPlace)
Feb-07-23 01:51PM	The 7 Best Biotech Stocks to Buy for February 2023 (InvestorPlace)
Feb-02-23 02:19PM	The 7 Most Undervalued Biotech Stocks to Buy in February 2023 (InvestorPlace)
Jan-19-23 10:49AM	16 Stocks with the Lowest PE Ratio (Insider Monkey)
Jan-05-23 07:00AM	Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-27-22 02:53PM	2022 Year in Review: Layoffs hit Triangle biotech, pharma companies (American City Business Journals) -6.52%
Dec-12-22 01:41PM	Durham drugmaker to cut workforce by 25%, focus on new cancer drug (American City Business Journals)
Dec-08-22 05:00PM	Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update (GlobeNewswire)
Nov-29-22 12:00PM	Chimerix (CMRX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Nov-10-22 04:30PM	Chimerix Responds to Rubric Capital Management (GlobeNewswire) +14.92%
09:00AM	Rubric Capital Management Sends Letter to Chimerix Board of Directors (Business Wire)
Nov-07-22 06:06AM	Zacks.com featured highlights Chimerix, Vista Oil & Gas and Arcus Biosciences (Zacks) +7.18%
Nov-04-22 12:27PM	Durham drugmaker eyes potential roadmap to profitability after $238M deal (American City Business Journals)
07:46AM	Buy 3 of the Best Stocks by Using Net Income Ratio (Zacks)
Nov-03-22 08:15AM	Chimerix (CMRX) Beats Q3 Earnings Estimates (Zacks)
07:00AM	Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-01-22 10:01AM	Perrigo (PRGO) Earnings Expected to Grow: Should You Buy? (Zacks) +6.21%
Oct-27-22 04:30PM	Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022 (GlobeNewswire)
10:02AM	Chimerix (CMRX) Earnings Expected to Grow: What to Know Ahead of Q3 Release (Zacks)
Oct-26-22 11:52AM	Boston Scientific (BSX) Q3 Earnings Miss, Operating Margin Up (Zacks)
Sep-27-22 09:59PM	Durham pharma nets $238M for smallpox drug with more payouts lined up (American City Business Journals)
02:52PM	Emergent BioSolutions closes acquisition of smallpox drug from Chimerix (American City Business Journals)
10:13AM	Emergent (EBS) Acquires Worldwide Rights to Smallpox Antiviral (Zacks)
Sep-26-22 04:05PM	Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions (GlobeNewswire)
Sep-10-22 09:16AM	Institutional investors own a significant stake of 49% in Chimerix, Inc. (NASDAQ:CMRX) (Simply Wall St.)
Sep-06-22 07:00AM	Chimerix to Present at H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire) -6.31%
Sep-01-22 08:48AM	Implied Volatility Surging for Chimerix (CMRX) Stock Options (Zacks)
Aug-30-22 02:17PM	Durham pharma locks down $680M deal with drug suddenly in high demand (American City Business Journals)
Aug-29-22 10:45AM	Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox (GlobeNewswire) +7.87%
Aug-17-22 09:29AM	7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher (InvestorPlace)
Aug-09-22 04:00AM	Chimerix (CMRX) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-08-22 04:01PM	Chimerix Reports Second Quarter 2022 Financial Results and Provides Operational Update (GlobeNewswire) -11.94%
07:00AM	Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs (GlobeNewswire)
Aug-02-22 07:00AM	Chimerix to Present at Wedbush PacGrow Healthcare Conference (GlobeNewswire)
Aug-01-22 04:01PM	Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Update on August 8, 2022 (GlobeNewswire)
Jul-25-22 04:30PM	Siga, Peers Rise on Optimism Over Monkeypox Therapies (Bloomberg) +10.87%
09:42AM	WHO declares Monkeypox a global health emergency (Yahoo Finance Video)
Jul-16-22 09:45AM	Is Chimerix (NASDAQ:CMRX) In A Good Position To Invest In Growth? (Simply Wall St.)
Jun-24-22 03:08PM	As monkeypox spreads, Durham firm getting plenty of attention (American City Business Journals) +13.19%
10:37AM	Chimerix gets up to $25.3 mln contract from Canada for smallpox drug (Reuters)
10:06AM	Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada (GlobeNewswire)
Jun-23-22 09:15AM	Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement (GlobeNewswire) +12.35%
Jun-22-22 07:00AM	7 Penny Stocks That Could Triple in 2022 (InvestorPlace)
Jun-16-22 09:10AM	Insiders who bought stock earlier this year lose -US$93k as Chimerix, Inc. (NASDAQ:CMRX) drops to US$120m (Simply Wall St.)
Jun-09-22 06:28AM	7 Monkeypox Stocks That May Take Off in Q2 (InvestorPlace) -5.56%
Jun-01-22 04:30PM	Chimerix to Present at Jefferies Global Healthcare Conference (GlobeNewswire)
May-24-22 08:04AM	Triangle market caps keep tanking Duke economist explains the volatility (American City Business Journals) -22.98%
05:55AM	Are These 4 Stocks Smart Buys With the Monkeypox Outbreak? (Motley Fool)
May-23-22 11:39AM	Why Emergent BioSolutions Stock Is Jumping Today (Motley Fool)
06:14AM	The Zacks Analyst Blog Highlights Emergent BioSolutions, Chimerix and SIGA Technologies (Zacks)
05:13AM	3 Monkeypox Stocks That Soared Last Week (Motley Fool)
May-20-22 08:38AM	Monkeypox Fears Drive Smallpox Antiviral Makers Higher (Zacks) +6.82%
May-18-22 11:41AM	Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates (Zacks)
May-17-22 04:15PM	Chimerix to Present at H.C. Wainwright Global Investment Conference (GlobeNewswire) +5.42%
09:08AM	Chimerix (CMRX) Plunges on Unfavorable Pipeline Updates (Zacks)
May-16-22 04:46PM	Durham firm Chimerix sells smallpox drug in $337M deal, but stock slides 60% (American City Business Journals) -60.85%
02:00PM	Chimerix (CMRX) Q1 2022 Earnings Call Transcript (Motley Fool)
12:05PM	Gaithersburg's Emergent BioSolutions to acquire smallpox drug from Chimerix (American City Business Journals)

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MIDDLETON FRED A	Director	Nov 17	Buy	0.96	17,295	16,522	100,000	Nov 20 03:28 PM
MIDDLETON FRED A	Director	Nov 10	Buy	0.92	2,705	2,489	82,705	Nov 13 04:39 PM
Jakeman David	VP of Finance and Accounting	Sep 28	Sale	0.99	3,610	3,584	133,142	Sep 28 04:17 PM
MIDDLETON FRED A	Director	Sep 25	Buy	0.98	20,000	19,636	80,000	Sep 26 03:58 PM
Andriole Michael T.	Chief Business Officer and CFO	May 18	Buy	1.14	51,700	59,150	357,015	May 19 11:41 AM
Sherman Michael A.	Chief Executive Officer	May 12	Buy	1.12	87,000	97,652	87,000	May 16 04:05 PM
DEMSKI MARTHA J	Director	May 10	Buy	1.11	18,000	19,980	72,055	May 11 12:26 PM
Meyer Robert J.	Director	May 08	Buy	1.14	8,750	9,975	35,150	May 10 12:51 PM
MIDDLETON FRED A	Director	Mar 28	Buy	1.21	20,000	24,152	60,000	Mar 29 12:41 PM
Jakeman David	Principal Accounting Officer	Jan 26	Sale	1.76	3,230	5,686	136,752	Jan 26 05:23 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CMRX

Chimerix Inc

Upgrade your FINVIZ experience